During carcinogenesis, cells undergo genome-wide hypomethylation and aberrant methylation of CpG islands. The chains of signaling driving such changes are not understood (for a review see Jaenisch and Bird, 2003) . In human cancers, certain genes are targets of aberrant methylation of promoter region CpG islands and this may cause the epigenetic silencing of tumor suppressor genes. Other CpG islands are well protected from this silencing mechanism, even if hypermethylation pressure is enhanced by forced overexpression of DNMT1 (Jaenisch and Bird, 2003) . One factor for protection could be sequence context (Feltus et al., 2003) . In 1997, Caiafa's group presented the first evidence that polyADP-ribosylation could be involved (Zardo et al., 1997) . Inhibition of PARP-1 induced aberrant methylation of a CpG island in the promoter of the Htf9 gene, demonstrating that it was not unmethylatable due to sequence context (Zardo and Caiafa, 1998) . In the present report, the same group now provides a plausible mechanism for how PARP-1 could operate as a negative regulator of DNA methylation (Reale et al., 2005) . Following activation, PARP-1 forms multiple polymers of ADP-ribose that become covalently attached to the enzyme itself. With the help of its long polymer arms, PARP-1 recruits DNMT1 into a complex and blocks its catalytic activity. Thus, PARP-1 becomes a positive regulator of epigenetic stability by protecting CpG islands from aberrant hypermethylation.
The mechanisms of targeting and activation of PARP-1 at CpG islands are not known. With its two zinc fingers, PARP-1 binds to and is activated by DNA strand breaks (for a review see Rouleau et al., 2004) . Another option is that PARP-1 binds to specific undamaged linear and stem-loop DNA structures, including some specific double-stranded sequences, which may be more potent activators of PARP-1s catalytic function than damaged DNA. PARP-1 can also be stimulated by association with proteins, such as transcription factors or transcriptional coactivators (for a review see Kraus and Lis, 2003; Rouleau et al., 2004) . Finally, PARP-1 operates at the interface of transcriptional activation and chromatin decondensation. Spradlings group demonstrate the colocalization of PARP-1 activity in areas of chromatin decondensation ('puffs') and high transcriptional activity in Drosophila and, most importantly, the critical dependence of these processes on PARP-1 function (Tulin and Spradling, 2003) . It will be a rewarding challenge to elucidate the targeting and the activating principle for PARP-1 in silencing DNA methylation.
DNMT1 is just the latest example of a protein being recruited into a complex by PARP-1-bound polymers. Several proteins of the genome surveillance system, such as p53, p21, DNA-PK, MSH6, XPA, and XRCC1 contain a polymer-binding sequence motif (Pleschke et al., 2000) . All these proteins form a tight complex with automodified PARP-1 but not with polymer-free enzyme. A particularly impressive example has been demonstrated in living cells for the assembly of the base excision repair complex (El-Khamisy et al., 2003; Okano et al., 2003) . Within less than 2 min of DNA base damage, PARP-1 forms ADP-ribose polymers and recruits XRCC1 to repair foci. Mutations in the polymer-binding site abrogate polymer-binding and recruitment of XRCC1 to repair foci. In this case, the interaction of XRCC1 with its other partners to form a functional repair complex, such as DNA ligase III or DNA polymerases b and e, is not impaired (El-Khamisy et al., 2003; Okano et al., 2003) . Another examplealbeit with different outcome -is the tumor suppressor protein p53. Both p53 and PARP-1 are activated by DNA breaks, but the PARP-1-bound polymers recruit p53 into a complex and prevent it from acting as a transcription factor. p53 contains three polymer-binding sequence motifs in the sequence-specific DNA-binding domain (Malanga et al., 1998) . Finally, PARP-1 may operate in yet another mode, this time activating the dormant catalytic activities of DNA topoisomerase I getting stuck on DNA breaks. Topo I controls DNA supercoiling, allowing topological changes that are necessary for DNA transactions. However, when operating on damaged DNA, the enzyme may get trapped in a covalent complex with DNA and pose a threat to genomic stability. PARP-1-bound polymers target two sequence motifs in topo I and reactivate two specific domain functions of these enzymes (Malanga and Althaus, 2004) . As a result, topo I removes itself from DNA and repairs the damage. Thus, PARP-1 also plays a role in the constitutive maintenance of genomic stability.
Proteins bonded into a complex with PARP-1 can be released by the enzyme poly(ADP-ribose)glycohydrolase (PARG), which degrades polymers both endo-and exoglycosidically. In fact, ADP-ribose polymers have a relatively short half-life in vivo regardless whether PARP-1 is activated by DNA damage or during transcription (for a review see Rouleau et al., 2004) . It will therefore be of considerable interest to see how interference with PARG activity affects DNA methylation. Finally, it is possible that DNMT1 associates with ADP-ribose polymers that were synthesized by other members of the PARP family (for a review see Rouleau et al., 2004) . In addition, most of these PARPs engage in a heteromodification reaction leading to the posttranslational poly ADP-ribosylation of other proteins. Several of these have been implicated in chromatin remodeling and they could interact with DNMT1 via attached polymers (Rouleau et al., 2004) .
